Immunic (IMUX) Treasury Shares (2013 - 2014)

Immunic (IMUX) posted Treasury Shares of $12.5 million for Q1 2014, down 8.79% sequentially from $13.7 million in Q4 2013.

Immunic (IMUX) Treasury Shares (2013 - 2014) Analysis & Trends

Immunic has reported Treasury Shares for 2 years, with the latest figure at $12.5 million in Q1 2014.

Quarterly Treasury Shares changed N/A year-over-year to $12.5 million in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $12.5 million (changed N/A YoY) and the FY2013 annual result came in at $13.7 million, up 95.36% from the prior year.
Treasury Shares retreated to $12.5 million in Q1 2014 per IMUX's latest filing, from $13.7 million in the prior quarter.
Over five years, Treasury Shares peaked at $13.7 million in Q4 2013 and troughed at $12.5 million in Q1 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Immunic	682.77 Mn	682.77 Mn	-	-

Download Data